Clinical Trial Update: Equivalence of Triferic® (Ferric Pyrophosphate Citrate) Administered Via Hemodialysate and Intravenously to Adult CKD-5HD Patients [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial update on equivalence of Triferic administered via hemodialysate versus IV in adult end-stage renal disease patients; results posted after compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• Triferic (ferric pyrophosphate)

Snippet

Sponsor: Rockwell Medical Technologies, Inc. | Conditions: End Stage Renal Disease | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-11-16